iCAD Takes Aim At R2 Technology With $30 Mil. CADx Acquisition
This article was originally published in The Gray Sheet
Executive Summary
iCAD will deepen its computer-assisted detection portfolio by developing applications for CADx' Second Look platform to identify cardiovascular disease and lung and colon cancers